Stay updated on Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Advanced Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed from the history, reflecting a site-level update that does not affect trial data or user interaction. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedRemoved the administrative notice about government funding and operating status links (cc.nih.gov and opm.gov).SummaryDifference0.3%

- Check49 days agoChange DetectedThe new screenshot shows minor visual adjustments to the page header and spacing, while the version list remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check70 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference8%

- Check78 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.2%

- Check92 days agoChange DetectedVersion bump from v3.0.1 to v3.0.2 and removal of the Back to Top element. Overall, no significant changes to core content or critical functionality.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.